Epstein Secrets

asted revenues and expenses highlighted above and was detanitheil hi he reawnable bawd on guideline company indications. According to management. the Company\ , term EBIT margin is expected to be higher than the average and median of the guideline company indications as a result of the anticipated increas

9 99.9 11.3% 2014 155.3 111.7 11.8% CAGR: 2009-14 Source: Datamonitor 10.1% DATAMONITOR • Sources: Standard & Poor's Industry Surveys (n, the Datamonitor Group, and information provided by management. CONFIDENTIAL I WTAS LLC 13 EFTA00307408 WTAS ALIPHCOM - COMMON EQUITY VALUATION REPORT As of June 20

asted revenues and expenses highlighted above and was detanitheil hi he reawnable bawd on guideline company indications. According to management. the Company\ , term EBIT margin is expected to be higher than the average and median of the guideline company indications as a result of the anticipated increas

9 99.9 11.3% 2014 155.3 111.7 11.8% CAGR: 2009-14 Source: Datamonitor 10.1% DATAMONITOR • Sources: Standard & Poor's Industry Surveys (n, the Datamonitor Group, and information provided by management. CONFIDENTIAL I WTAS LLC 13 EFTA00307307 WTAS ALIPHCOM - COMMON EQUITY VALUATION REPORT As of June 20

asted revenues and expenses highlighted above and was detanitheil hi he reawnable bawd on guideline company indications. According to management. the Company\ , term EBIT margin is expected to be higher than the average and median of the guideline company indications as a result of the anticipated increas

9 99.9 11.3% 2014 155.3 111.7 11.8% CAGR: 2009-14 Source: Datamonitor 10.1% DATAMONITOR • Sources: Standard & Poor's Industry Surveys (n, the Datamonitor Group, and information provided by management. CONFIDENTIAL I WTAS LLC 13 EFTA00307206 WTAS ALIPHCOM - COMMON EQUITY VALUATION REPORT As of June 20